Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06544434
PHASE2

Laser Acupuncture for Meniere Disease

Sponsor: Beijing Tongren Hospital

View on ClinicalTrials.gov

Summary

Objective: To evaluate the effect of laser acupuncture for the patients Meniere disease. Methods: We enrolled 324 patients at Beijing Tongren Hospital. Patients completed outcome measures at baseline, 3 months, 6 months, and 12 months. Video head impulse test (vHIT), The Caloric Test, Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry (PTA), and visual scale of ear stuffiness to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.

Official title: Laser Acupuncture for Meniere Disease: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

324

Start Date

2021-05-01

Completion Date

2024-10-20

Last Updated

2024-08-09

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Multiwave Locked System (MLS) laser (Mphi laser, ASA Srl, Vicenza, Italy)

MLS laser is a class IV NIR laser with two synchronized sources (905 nm with 75 W peak power, pulsed mode; 808 nm with power 1 W, continuous mode). Both laser beams were synchronized, the locked waves work with the range 1-2000 Hz.

DRUG

Betahistine Mesylate tablet

Betahistine Mesylate tablet (Merislon, Eisai Co., Ltd., China) with the treatment of 6 mg, 3 times a day.

Locations (1)

Beijing TongRen Hospital, Capital Medical University

Beijing, China